Pan-cancer analysis of HS6ST2: associations with prognosis, tumor immunity, and drug resistance

CONCLUSION: Overall, this study provides a comprehensive understanding of HS6ST2 in CESC, KICH, LUAD, and STAD, emphasizing its potential as a prognostic biomarker and therapeutic target.PMID:38586106 | PMC:PMC10994782 | DOI:10.62347/NCPH5416

Source: American Journal of Translational Research - April 8, 2024 Category: Research Authors: Luxin Huang Sidra Irshad Ulfat Sultana Saqib Ali Ayesha Jamil Ayesha Zubair Rizwana Sultan Mostafa A Abdel-Maksoud Ayman Mubarak Bandar M Almunqedhi Taghreed N Almanaa Abdul Malik Abdulaziz Alamri Ahmad S Kodous Mohammed Mares Mohamed Y Zaky Syeda Saba Sa Source Type: research